nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—rheumatoid arthritis—Acetylsalicylic acid—coronary artery disease	0.215	0.588	CpDpCtD
Lidocaine—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.15	0.412	CpDpCtD
Lidocaine—SLC22A5—Niacin—coronary artery disease	0.0163	0.0394	CbGbCtD
Lidocaine—SCN5A—purkinje fiber—coronary artery disease	0.0136	0.348	CbGeAlD
Lidocaine—CYP2C8—Fenofibrate—coronary artery disease	0.0117	0.0281	CbGbCtD
Lidocaine—SLC22A5—Furosemide—coronary artery disease	0.0107	0.0259	CbGbCtD
Lidocaine—CYP2B6—Clopidogrel—coronary artery disease	0.0107	0.0258	CbGbCtD
Lidocaine—CYP3A7—Eplerenone—coronary artery disease	0.0104	0.0251	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0104	0.0251	CbGbCtD
Lidocaine—CYP2C8—Gemfibrozil—coronary artery disease	0.00932	0.0225	CbGbCtD
Lidocaine—ABCB1—Ticagrelor—coronary artery disease	0.00886	0.0214	CbGbCtD
Lidocaine—CYP3A5—Clopidogrel—coronary artery disease	0.00841	0.0203	CbGbCtD
Lidocaine—CYP2C9—Fenofibrate—coronary artery disease	0.00813	0.0196	CbGbCtD
Lidocaine—CYP2C8—Clopidogrel—coronary artery disease	0.00808	0.0195	CbGbCtD
Lidocaine—CYP3A5—Eplerenone—coronary artery disease	0.00781	0.0189	CbGbCtD
Lidocaine—CYP1A2—Gemfibrozil—coronary artery disease	0.00722	0.0174	CbGbCtD
Lidocaine—CYP2C8—Pitavastatin—coronary artery disease	0.00706	0.0171	CbGbCtD
Lidocaine—SCN5A—endocardium—coronary artery disease	0.00701	0.18	CbGeAlD
Lidocaine—CYP3A7—Simvastatin—coronary artery disease	0.00671	0.0162	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00671	0.0162	CbGbCtD
Lidocaine—SCN5A—sinoatrial node—coronary artery disease	0.00664	0.17	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00657	0.0159	CbGbCtD
Lidocaine—CYP3A7—Lovastatin—coronary artery disease	0.00657	0.0159	CbGbCtD
Lidocaine—CYP2C9—Gemfibrozil—coronary artery disease	0.0065	0.0157	CbGbCtD
Lidocaine—CYP2B6—Simvastatin—coronary artery disease	0.00639	0.0154	CbGbCtD
Lidocaine—CYP1A2—Clopidogrel—coronary artery disease	0.00626	0.0151	CbGbCtD
Lidocaine—CYP3A7—Atorvastatin—coronary artery disease	0.00598	0.0144	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00598	0.0144	CbGbCtD
Lidocaine—CYP2B6—Atorvastatin—coronary artery disease	0.0057	0.0138	CbGbCtD
Lidocaine—CYP2C9—Clopidogrel—coronary artery disease	0.00564	0.0136	CbGbCtD
Lidocaine—ABCB1—Clopidogrel—coronary artery disease	0.00547	0.0132	CbGbCtD
Lidocaine—ABCB1—Perindopril—coronary artery disease	0.00547	0.0132	CbGbCtD
Lidocaine—CYP3A5—Rosuvastatin—coronary artery disease	0.00542	0.0131	CbGbCtD
Lidocaine—CYP3A4—Ticagrelor—coronary artery disease	0.00531	0.0128	CbGbCtD
Lidocaine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00508	0.0123	CbGbCtD
Lidocaine—CYP3A5—Simvastatin—coronary artery disease	0.00504	0.0122	CbGbCtD
Lidocaine—CYP3A5—Pravastatin—coronary artery disease	0.00493	0.0119	CbGbCtD
Lidocaine—CYP3A5—Lovastatin—coronary artery disease	0.00493	0.0119	CbGbCtD
Lidocaine—CYP2C9—Pitavastatin—coronary artery disease	0.00493	0.0119	CbGbCtD
Lidocaine—CYP2C8—Simvastatin—coronary artery disease	0.00484	0.0117	CbGbCtD
Lidocaine—CYP2C9—Valsartan—coronary artery disease	0.00479	0.0116	CbGbCtD
Lidocaine—ABCB1—Telmisartan—coronary artery disease	0.00478	0.0115	CbGbCtD
Lidocaine—ABCB1—Pitavastatin—coronary artery disease	0.00478	0.0115	CbGbCtD
Lidocaine—CYP2C8—Pravastatin—coronary artery disease	0.00474	0.0114	CbGbCtD
Lidocaine—CYP2C8—Lovastatin—coronary artery disease	0.00474	0.0114	CbGbCtD
Lidocaine—CYP3A4—Fenofibrate—coronary artery disease	0.00473	0.0114	CbGbCtD
Lidocaine—ABCB1—Enalapril—coronary artery disease	0.00453	0.0109	CbGbCtD
Lidocaine—ABCB1—Lisinopril—coronary artery disease	0.00453	0.0109	CbGbCtD
Lidocaine—CYP3A5—Atorvastatin—coronary artery disease	0.00449	0.0108	CbGbCtD
Lidocaine—CYP2C8—Atorvastatin—coronary artery disease	0.00432	0.0104	CbGbCtD
Lidocaine—CYP3A5—Losartan—coronary artery disease	0.00411	0.00991	CbGbCtD
Lidocaine—CYP2C8—Losartan—coronary artery disease	0.00395	0.00953	CbGbCtD
Lidocaine—CYP2D6—Niacin—coronary artery disease	0.00391	0.00943	CbGbCtD
Lidocaine—ABCB1—Timolol—coronary artery disease	0.00385	0.0093	CbGbCtD
Lidocaine—CYP3A4—Gemfibrozil—coronary artery disease	0.00378	0.00913	CbGbCtD
Lidocaine—CYP2C9—Rosuvastatin—coronary artery disease	0.00363	0.00877	CbGbCtD
Lidocaine—CYP2D6—Timolol—coronary artery disease	0.00363	0.00877	CbGbCtD
Lidocaine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00354	0.00854	CbGbCtD
Lidocaine—ABCB1—Ezetimibe—coronary artery disease	0.00353	0.00851	CbGbCtD
Lidocaine—CYP2C9—cardial valve—coronary artery disease	0.0035	0.0897	CbGeAlD
Lidocaine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00344	0.00829	CbGbCtD
Lidocaine—ABCB1—Captopril—coronary artery disease	0.00339	0.00819	CbGbCtD
Lidocaine—CYP2C9—Simvastatin—coronary artery disease	0.00338	0.00815	CbGbCtD
Lidocaine—CYP2C9—Lovastatin—coronary artery disease	0.0033	0.00798	CbGbCtD
Lidocaine—CYP2C9—Pravastatin—coronary artery disease	0.0033	0.00798	CbGbCtD
Lidocaine—CYP3A4—Clopidogrel—coronary artery disease	0.00328	0.00791	CbGbCtD
Lidocaine—ABCB1—Simvastatin—coronary artery disease	0.00328	0.00791	CbGbCtD
Lidocaine—ABCB1—Pravastatin—coronary artery disease	0.00321	0.00774	CbGbCtD
Lidocaine—ABCB1—Lovastatin—coronary artery disease	0.00321	0.00774	CbGbCtD
Lidocaine—CYP2D6—Captopril—coronary artery disease	0.0032	0.00772	CbGbCtD
Lidocaine—CYP2D6—Simvastatin—coronary artery disease	0.00309	0.00745	CbGbCtD
Lidocaine—CYP1A2—Losartan—coronary artery disease	0.00306	0.00737	CbGbCtD
Lidocaine—CYP3A4—Eplerenone—coronary artery disease	0.00305	0.00736	CbGbCtD
Lidocaine—CYP2D6—Pravastatin—coronary artery disease	0.00302	0.00729	CbGbCtD
Lidocaine—CYP2D6—Lovastatin—coronary artery disease	0.00302	0.00729	CbGbCtD
Lidocaine—CYP2C9—Atorvastatin—coronary artery disease	0.00301	0.00727	CbGbCtD
Lidocaine—ABCB1—Atorvastatin—coronary artery disease	0.00292	0.00705	CbGbCtD
Lidocaine—CYP2C9—Losartan—coronary artery disease	0.00275	0.00665	CbGbCtD
Lidocaine—CYP2D6—Atorvastatin—coronary artery disease	0.00275	0.00664	CbGbCtD
Lidocaine—CYP3A4—Enalapril—coronary artery disease	0.00272	0.00656	CbGbCtD
Lidocaine—ABCB1—Losartan—coronary artery disease	0.00267	0.00645	CbGbCtD
Lidocaine—CYP3A4—Rosuvastatin—coronary artery disease	0.00211	0.0051	CbGbCtD
Lidocaine—CYP3A4—Ezetimibe—coronary artery disease	0.00211	0.0051	CbGbCtD
Lidocaine—CYP3A4—Simvastatin—coronary artery disease	0.00196	0.00474	CbGbCtD
Lidocaine—CYP3A4—Lovastatin—coronary artery disease	0.00192	0.00464	CbGbCtD
Lidocaine—CYP3A4—Pravastatin—coronary artery disease	0.00192	0.00464	CbGbCtD
Lidocaine—CYP3A4—Atorvastatin—coronary artery disease	0.00175	0.00422	CbGbCtD
Lidocaine—CYP3A4—Losartan—coronary artery disease	0.0016	0.00386	CbGbCtD
Lidocaine—EGFR—heart—coronary artery disease	0.00068	0.0174	CbGeAlD
Lidocaine—SCN5A—cardiac ventricle—coronary artery disease	0.00059	0.0151	CbGeAlD
Lidocaine—SCN5A—myocardium—coronary artery disease	0.000555	0.0142	CbGeAlD
Lidocaine—SCN4A—heart—coronary artery disease	0.000499	0.0128	CbGeAlD
Lidocaine—SCN3A—heart—coronary artery disease	0.000388	0.00995	CbGeAlD
Lidocaine—SCN5A—heart—coronary artery disease	0.000387	0.00992	CbGeAlD
Lidocaine—SCN5A—cardiovascular system—coronary artery disease	0.000365	0.00936	CbGeAlD
Lidocaine—SLC22A5—cardiac ventricle—coronary artery disease	0.000343	0.00878	CbGeAlD
Lidocaine—SCN5A—cardiac atrium—coronary artery disease	0.000331	0.00848	CbGeAlD
Lidocaine—SCN2A—blood—coronary artery disease	0.00033	0.00845	CbGeAlD
Lidocaine—SLC22A5—myocardium—coronary artery disease	0.000322	0.00826	CbGeAlD
Lidocaine—SCN10A—blood—coronary artery disease	0.000318	0.00815	CbGeAlD
Lidocaine—SCN3A—blood—coronary artery disease	0.00029	0.00742	CbGeAlD
Lidocaine—SCN5A—blood—coronary artery disease	0.000289	0.0074	CbGeAlD
Lidocaine—SLC22A5—heart—coronary artery disease	0.000225	0.00577	CbGeAlD
Lidocaine—Procainamide—SLC22A3—coronary artery disease	0.000212	0.456	CrCbGaD
Lidocaine—CYP2B6—heart—coronary artery disease	0.000195	0.00501	CbGeAlD
Lidocaine—CYP2C9—heart—coronary artery disease	0.000194	0.00496	CbGeAlD
Lidocaine—SLC22A5—cardiac atrium—coronary artery disease	0.000192	0.00493	CbGeAlD
Lidocaine—CYP2B6—cardiovascular system—coronary artery disease	0.000184	0.00472	CbGeAlD
Lidocaine—CYP2C9—cardiovascular system—coronary artery disease	0.000183	0.00468	CbGeAlD
Lidocaine—Bupivacaine—CYP2C19—coronary artery disease	0.000178	0.383	CrCbGaD
Lidocaine—SLC22A5—blood—coronary artery disease	0.000168	0.0043	CbGeAlD
Lidocaine—CYP2C8—blood—coronary artery disease	0.000163	0.00416	CbGeAlD
Lidocaine—CYP1A2—blood—coronary artery disease	0.000152	0.0039	CbGeAlD
Lidocaine—CYP3A5—blood—coronary artery disease	0.000147	0.00376	CbGeAlD
Lidocaine—CYP2B6—blood—coronary artery disease	0.000146	0.00374	CbGeAlD
Lidocaine—CYP2C9—blood—coronary artery disease	0.000144	0.0037	CbGeAlD
Lidocaine—CYP3A4—blood—coronary artery disease	0.00011	0.00282	CbGeAlD
Lidocaine—CYP2D6—blood—coronary artery disease	0.000108	0.00278	CbGeAlD
Lidocaine—ABCB1—heart—coronary artery disease	0.000104	0.00268	CbGeAlD
Lidocaine—ABCB1—cardiovascular system—coronary artery disease	9.86e-05	0.00253	CbGeAlD
Lidocaine—ABCB1—blood—coronary artery disease	7.8e-05	0.002	CbGeAlD
Lidocaine—Tocainide—ALB—coronary artery disease	7.49e-05	0.161	CrCbGaD
Lidocaine—Nervous system disorder—Losartan—coronary artery disease	6.42e-05	0.000602	CcSEcCtD
Lidocaine—Dyspnoea—Captopril—coronary artery disease	6.41e-05	0.000601	CcSEcCtD
Lidocaine—Urticaria—Olmesartan—coronary artery disease	6.4e-05	0.0006	CcSEcCtD
Lidocaine—Somnolence—Captopril—coronary artery disease	6.39e-05	0.000599	CcSEcCtD
Lidocaine—Feeling abnormal—Pravastatin—coronary artery disease	6.39e-05	0.000599	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Telmisartan—coronary artery disease	6.38e-05	0.000599	CcSEcCtD
Lidocaine—Hypotension—Furosemide—coronary artery disease	6.34e-05	0.000595	CcSEcCtD
Lidocaine—Vision blurred—Timolol—coronary artery disease	6.34e-05	0.000594	CcSEcCtD
Lidocaine—Hyperhidrosis—Losartan—coronary artery disease	6.33e-05	0.000594	CcSEcCtD
Lidocaine—Pain—Telmisartan—coronary artery disease	6.32e-05	0.000593	CcSEcCtD
Lidocaine—Agitation—Ramipril—coronary artery disease	6.32e-05	0.000593	CcSEcCtD
Lidocaine—Hypersensitivity—Simvastatin—coronary artery disease	6.32e-05	0.000592	CcSEcCtD
Lidocaine—Asthenia—Eplerenone—coronary artery disease	6.31e-05	0.000592	CcSEcCtD
Lidocaine—Angioedema—Ramipril—coronary artery disease	6.29e-05	0.000589	CcSEcCtD
Lidocaine—Paraesthesia—Perindopril—coronary artery disease	6.27e-05	0.000588	CcSEcCtD
Lidocaine—Urticaria—Niacin—coronary artery disease	6.25e-05	0.000586	CcSEcCtD
Lidocaine—Nausea—Acetylsalicylic acid—coronary artery disease	6.24e-05	0.000585	CcSEcCtD
Lidocaine—Erythema—Lisinopril—coronary artery disease	6.24e-05	0.000585	CcSEcCtD
Lidocaine—Dyspnoea—Perindopril—coronary artery disease	6.22e-05	0.000584	CcSEcCtD
Lidocaine—Dizziness—Fenofibrate—coronary artery disease	6.21e-05	0.000582	CcSEcCtD
Lidocaine—Somnolence—Perindopril—coronary artery disease	6.21e-05	0.000582	CcSEcCtD
Lidocaine—Feeling abnormal—Trandolapril—coronary artery disease	6.2e-05	0.000582	CcSEcCtD
Lidocaine—Feeling abnormal—Enalapril—coronary artery disease	6.18e-05	0.000579	CcSEcCtD
Lidocaine—Urticaria—Pravastatin—coronary artery disease	6.16e-05	0.000577	CcSEcCtD
Lidocaine—Asthenia—Simvastatin—coronary artery disease	6.15e-05	0.000577	CcSEcCtD
Lidocaine—Angioedema—Timolol—coronary artery disease	6.15e-05	0.000576	CcSEcCtD
Lidocaine—Tension—Lisinopril—coronary artery disease	6.12e-05	0.000574	CcSEcCtD
Lidocaine—Hypotension—Losartan—coronary artery disease	6.12e-05	0.000574	CcSEcCtD
Lidocaine—Dysgeusia—Lisinopril—coronary artery disease	6.11e-05	0.000573	CcSEcCtD
Lidocaine—Dizziness—Clopidogrel—coronary artery disease	6.1e-05	0.000572	CcSEcCtD
Lidocaine—Paraesthesia—Furosemide—coronary artery disease	6.09e-05	0.000571	CcSEcCtD
Lidocaine—Feeling abnormal—Telmisartan—coronary artery disease	6.09e-05	0.000571	CcSEcCtD
Lidocaine—Dizziness—Lovastatin—coronary artery disease	6.06e-05	0.000568	CcSEcCtD
Lidocaine—Nervousness—Lisinopril—coronary artery disease	6.06e-05	0.000568	CcSEcCtD
Lidocaine—Loss of consciousness—Ramipril—coronary artery disease	6.05e-05	0.000567	CcSEcCtD
Lidocaine—Back pain—Lisinopril—coronary artery disease	6.03e-05	0.000566	CcSEcCtD
Lidocaine—Somnolence—Furosemide—coronary artery disease	6.03e-05	0.000566	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Perindopril—coronary artery disease	6.03e-05	0.000565	CcSEcCtD
Lidocaine—Urticaria—Trandolapril—coronary artery disease	5.98e-05	0.000561	CcSEcCtD
Lidocaine—Pain—Perindopril—coronary artery disease	5.97e-05	0.00056	CcSEcCtD
Lidocaine—Vomiting—Fenofibrate—coronary artery disease	5.97e-05	0.00056	CcSEcCtD
Lidocaine—Hypersensitivity—Valsartan—coronary artery disease	5.96e-05	0.000559	CcSEcCtD
Lidocaine—Convulsion—Ramipril—coronary artery disease	5.96e-05	0.000559	CcSEcCtD
Lidocaine—Urticaria—Enalapril—coronary artery disease	5.96e-05	0.000558	CcSEcCtD
Lidocaine—Dizziness—Ezetimibe—coronary artery disease	5.94e-05	0.000557	CcSEcCtD
Lidocaine—Feeling abnormal—Captopril—coronary artery disease	5.92e-05	0.000556	CcSEcCtD
Lidocaine—Rash—Fenofibrate—coronary artery disease	5.92e-05	0.000555	CcSEcCtD
Lidocaine—Dermatitis—Fenofibrate—coronary artery disease	5.91e-05	0.000554	CcSEcCtD
Lidocaine—Loss of consciousness—Timolol—coronary artery disease	5.91e-05	0.000554	CcSEcCtD
Lidocaine—Headache—Fenofibrate—coronary artery disease	5.88e-05	0.000551	CcSEcCtD
Lidocaine—Vision blurred—Lisinopril—coronary artery disease	5.88e-05	0.000551	CcSEcCtD
Lidocaine—Paraesthesia—Losartan—coronary artery disease	5.88e-05	0.000551	CcSEcCtD
Lidocaine—Urticaria—Telmisartan—coronary artery disease	5.87e-05	0.000551	CcSEcCtD
Lidocaine—Vomiting—Clopidogrel—coronary artery disease	5.87e-05	0.00055	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Furosemide—coronary artery disease	5.86e-05	0.000549	CcSEcCtD
Lidocaine—Chest pain—Ramipril—coronary artery disease	5.86e-05	0.000549	CcSEcCtD
Lidocaine—Tremor—Lisinopril—coronary artery disease	5.85e-05	0.000548	CcSEcCtD
Lidocaine—Dyspnoea—Losartan—coronary artery disease	5.84e-05	0.000547	CcSEcCtD
Lidocaine—Anxiety—Ramipril—coronary artery disease	5.84e-05	0.000547	CcSEcCtD
Lidocaine—Vomiting—Lovastatin—coronary artery disease	5.83e-05	0.000546	CcSEcCtD
Lidocaine—Somnolence—Losartan—coronary artery disease	5.82e-05	0.000546	CcSEcCtD
Lidocaine—Dizziness—Eplerenone—coronary artery disease	5.82e-05	0.000546	CcSEcCtD
Lidocaine—Rash—Clopidogrel—coronary artery disease	5.82e-05	0.000546	CcSEcCtD
Lidocaine—Dermatitis—Clopidogrel—coronary artery disease	5.81e-05	0.000545	CcSEcCtD
Lidocaine—Asthenia—Valsartan—coronary artery disease	5.81e-05	0.000545	CcSEcCtD
Lidocaine—Hypertension—Timolol—coronary artery disease	5.81e-05	0.000545	CcSEcCtD
Lidocaine—Pain—Furosemide—coronary artery disease	5.8e-05	0.000544	CcSEcCtD
Lidocaine—Hypersensitivity—Niacin—coronary artery disease	5.8e-05	0.000544	CcSEcCtD
Lidocaine—Asthenia—Olmesartan—coronary artery disease	5.78e-05	0.000542	CcSEcCtD
Lidocaine—Headache—Clopidogrel—coronary artery disease	5.78e-05	0.000542	CcSEcCtD
Lidocaine—Rash—Lovastatin—coronary artery disease	5.78e-05	0.000542	CcSEcCtD
Lidocaine—Dermatitis—Lovastatin—coronary artery disease	5.77e-05	0.000541	CcSEcCtD
Lidocaine—Feeling abnormal—Perindopril—coronary artery disease	5.75e-05	0.000539	CcSEcCtD
Lidocaine—Headache—Lovastatin—coronary artery disease	5.74e-05	0.000538	CcSEcCtD
Lidocaine—Chest pain—Timolol—coronary artery disease	5.73e-05	0.000537	CcSEcCtD
Lidocaine—Vomiting—Ezetimibe—coronary artery disease	5.72e-05	0.000536	CcSEcCtD
Lidocaine—Hypersensitivity—Pravastatin—coronary artery disease	5.71e-05	0.000536	CcSEcCtD
Lidocaine—Anxiety—Timolol—coronary artery disease	5.71e-05	0.000535	CcSEcCtD
Lidocaine—Angioedema—Lisinopril—coronary artery disease	5.7e-05	0.000535	CcSEcCtD
Lidocaine—Dizziness—Simvastatin—coronary artery disease	5.67e-05	0.000532	CcSEcCtD
Lidocaine—Rash—Ezetimibe—coronary artery disease	5.67e-05	0.000532	CcSEcCtD
Lidocaine—Dermatitis—Ezetimibe—coronary artery disease	5.66e-05	0.000531	CcSEcCtD
Lidocaine—Confusional state—Ramipril—coronary artery disease	5.66e-05	0.000531	CcSEcCtD
Lidocaine—Asthenia—Niacin—coronary artery disease	5.65e-05	0.00053	CcSEcCtD
Lidocaine—Headache—Ezetimibe—coronary artery disease	5.63e-05	0.000528	CcSEcCtD
Lidocaine—Anaphylactic shock—Ramipril—coronary artery disease	5.61e-05	0.000527	CcSEcCtD
Lidocaine—Oedema—Ramipril—coronary artery disease	5.61e-05	0.000527	CcSEcCtD
Lidocaine—Pain—Losartan—coronary artery disease	5.6e-05	0.000525	CcSEcCtD
Lidocaine—Vomiting—Eplerenone—coronary artery disease	5.59e-05	0.000525	CcSEcCtD
Lidocaine—Feeling abnormal—Furosemide—coronary artery disease	5.59e-05	0.000524	CcSEcCtD
Lidocaine—Nausea—Fenofibrate—coronary artery disease	5.58e-05	0.000523	CcSEcCtD
Lidocaine—Asthenia—Pravastatin—coronary artery disease	5.56e-05	0.000521	CcSEcCtD
Lidocaine—Rash—Eplerenone—coronary artery disease	5.55e-05	0.00052	CcSEcCtD
Lidocaine—Urticaria—Perindopril—coronary artery disease	5.55e-05	0.00052	CcSEcCtD
Lidocaine—Hypersensitivity—Trandolapril—coronary artery disease	5.55e-05	0.00052	CcSEcCtD
Lidocaine—Dermatitis—Eplerenone—coronary artery disease	5.54e-05	0.00052	CcSEcCtD
Lidocaine—Confusional state—Timolol—coronary artery disease	5.53e-05	0.000519	CcSEcCtD
Lidocaine—Shock—Ramipril—coronary artery disease	5.52e-05	0.000518	CcSEcCtD
Lidocaine—Hypersensitivity—Enalapril—coronary artery disease	5.52e-05	0.000518	CcSEcCtD
Lidocaine—Headache—Eplerenone—coronary artery disease	5.51e-05	0.000517	CcSEcCtD
Lidocaine—Nervous system disorder—Ramipril—coronary artery disease	5.51e-05	0.000516	CcSEcCtD
Lidocaine—Anaphylactic shock—Timolol—coronary artery disease	5.49e-05	0.000515	CcSEcCtD
Lidocaine—Oedema—Timolol—coronary artery disease	5.49e-05	0.000515	CcSEcCtD
Lidocaine—Loss of consciousness—Lisinopril—coronary artery disease	5.48e-05	0.000514	CcSEcCtD
Lidocaine—Nausea—Clopidogrel—coronary artery disease	5.48e-05	0.000514	CcSEcCtD
Lidocaine—Vomiting—Simvastatin—coronary artery disease	5.45e-05	0.000511	CcSEcCtD
Lidocaine—Hypersensitivity—Telmisartan—coronary artery disease	5.45e-05	0.000511	CcSEcCtD
Lidocaine—Nausea—Lovastatin—coronary artery disease	5.44e-05	0.000511	CcSEcCtD
Lidocaine—Hyperhidrosis—Ramipril—coronary artery disease	5.43e-05	0.000509	CcSEcCtD
Lidocaine—Rash—Simvastatin—coronary artery disease	5.41e-05	0.000507	CcSEcCtD
Lidocaine—Dermatitis—Simvastatin—coronary artery disease	5.4e-05	0.000506	CcSEcCtD
Lidocaine—Asthenia—Trandolapril—coronary artery disease	5.4e-05	0.000506	CcSEcCtD
Lidocaine—Shock—Timolol—coronary artery disease	5.4e-05	0.000506	CcSEcCtD
Lidocaine—Feeling abnormal—Losartan—coronary artery disease	5.4e-05	0.000506	CcSEcCtD
Lidocaine—Urticaria—Furosemide—coronary artery disease	5.39e-05	0.000506	CcSEcCtD
Lidocaine—Nervous system disorder—Timolol—coronary artery disease	5.38e-05	0.000505	CcSEcCtD
Lidocaine—Asthenia—Enalapril—coronary artery disease	5.38e-05	0.000504	CcSEcCtD
Lidocaine—Headache—Simvastatin—coronary artery disease	5.37e-05	0.000504	CcSEcCtD
Lidocaine—Dizziness—Valsartan—coronary artery disease	5.35e-05	0.000502	CcSEcCtD
Lidocaine—Nausea—Ezetimibe—coronary artery disease	5.34e-05	0.000501	CcSEcCtD
Lidocaine—Dizziness—Olmesartan—coronary artery disease	5.33e-05	0.0005	CcSEcCtD
Lidocaine—Chest pain—Lisinopril—coronary artery disease	5.31e-05	0.000498	CcSEcCtD
Lidocaine—Hyperhidrosis—Timolol—coronary artery disease	5.31e-05	0.000498	CcSEcCtD
Lidocaine—Asthenia—Telmisartan—coronary artery disease	5.31e-05	0.000497	CcSEcCtD
Lidocaine—Anxiety—Lisinopril—coronary artery disease	5.29e-05	0.000496	CcSEcCtD
Lidocaine—Hypotension—Ramipril—coronary artery disease	5.25e-05	0.000492	CcSEcCtD
Lidocaine—Nausea—Eplerenone—coronary artery disease	5.23e-05	0.00049	CcSEcCtD
Lidocaine—Dizziness—Niacin—coronary artery disease	5.21e-05	0.000488	CcSEcCtD
Lidocaine—Urticaria—Losartan—coronary artery disease	5.2e-05	0.000488	CcSEcCtD
Lidocaine—Asthenia—Captopril—coronary artery disease	5.16e-05	0.000484	CcSEcCtD
Lidocaine—Vomiting—Valsartan—coronary artery disease	5.15e-05	0.000483	CcSEcCtD
Lidocaine—Confusional state—Lisinopril—coronary artery disease	5.13e-05	0.000481	CcSEcCtD
Lidocaine—Hypotension—Timolol—coronary artery disease	5.13e-05	0.000481	CcSEcCtD
Lidocaine—Dizziness—Pravastatin—coronary artery disease	5.13e-05	0.000481	CcSEcCtD
Lidocaine—Vomiting—Olmesartan—coronary artery disease	5.12e-05	0.00048	CcSEcCtD
Lidocaine—Rash—Valsartan—coronary artery disease	5.1e-05	0.000479	CcSEcCtD
Lidocaine—Dermatitis—Valsartan—coronary artery disease	5.1e-05	0.000478	CcSEcCtD
Lidocaine—Nausea—Simvastatin—coronary artery disease	5.09e-05	0.000478	CcSEcCtD
Lidocaine—Oedema—Lisinopril—coronary artery disease	5.09e-05	0.000477	CcSEcCtD
Lidocaine—Anaphylactic shock—Lisinopril—coronary artery disease	5.09e-05	0.000477	CcSEcCtD
Lidocaine—Rash—Olmesartan—coronary artery disease	5.08e-05	0.000476	CcSEcCtD
Lidocaine—Dermatitis—Olmesartan—coronary artery disease	5.08e-05	0.000476	CcSEcCtD
Lidocaine—Headache—Valsartan—coronary artery disease	5.07e-05	0.000476	CcSEcCtD
Lidocaine—Headache—Olmesartan—coronary artery disease	5.05e-05	0.000473	CcSEcCtD
Lidocaine—Paraesthesia—Ramipril—coronary artery disease	5.04e-05	0.000473	CcSEcCtD
Lidocaine—Shock—Lisinopril—coronary artery disease	5.01e-05	0.00047	CcSEcCtD
Lidocaine—Asthenia—Perindopril—coronary artery disease	5.01e-05	0.00047	CcSEcCtD
Lidocaine—Dyspnoea—Ramipril—coronary artery disease	5.01e-05	0.000469	CcSEcCtD
Lidocaine—Vomiting—Niacin—coronary artery disease	5.01e-05	0.000469	CcSEcCtD
Lidocaine—Hypersensitivity—Furosemide—coronary artery disease	5e-05	0.000469	CcSEcCtD
Lidocaine—Somnolence—Ramipril—coronary artery disease	4.99e-05	0.000468	CcSEcCtD
Lidocaine—Dizziness—Trandolapril—coronary artery disease	4.98e-05	0.000467	CcSEcCtD
Lidocaine—Rash—Niacin—coronary artery disease	4.96e-05	0.000465	CcSEcCtD
Lidocaine—Dermatitis—Niacin—coronary artery disease	4.96e-05	0.000465	CcSEcCtD
Lidocaine—Dizziness—Enalapril—coronary artery disease	4.96e-05	0.000465	CcSEcCtD
Lidocaine—Headache—Niacin—coronary artery disease	4.93e-05	0.000462	CcSEcCtD
Lidocaine—Paraesthesia—Timolol—coronary artery disease	4.93e-05	0.000462	CcSEcCtD
Lidocaine—Vomiting—Pravastatin—coronary artery disease	4.93e-05	0.000462	CcSEcCtD
Lidocaine—Hyperhidrosis—Lisinopril—coronary artery disease	4.92e-05	0.000462	CcSEcCtD
Lidocaine—Dyspnoea—Timolol—coronary artery disease	4.89e-05	0.000459	CcSEcCtD
Lidocaine—Dizziness—Telmisartan—coronary artery disease	4.89e-05	0.000459	CcSEcCtD
Lidocaine—Rash—Pravastatin—coronary artery disease	4.89e-05	0.000458	CcSEcCtD
Lidocaine—Dermatitis—Pravastatin—coronary artery disease	4.88e-05	0.000458	CcSEcCtD
Lidocaine—Somnolence—Timolol—coronary artery disease	4.88e-05	0.000458	CcSEcCtD
Lidocaine—Asthenia—Furosemide—coronary artery disease	4.87e-05	0.000457	CcSEcCtD
Lidocaine—Headache—Pravastatin—coronary artery disease	4.86e-05	0.000455	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Ramipril—coronary artery disease	4.85e-05	0.000455	CcSEcCtD
Lidocaine—Hypersensitivity—Losartan—coronary artery disease	4.82e-05	0.000452	CcSEcCtD
Lidocaine—Nausea—Valsartan—coronary artery disease	4.81e-05	0.000451	CcSEcCtD
Lidocaine—Nausea—Olmesartan—coronary artery disease	4.79e-05	0.000449	CcSEcCtD
Lidocaine—Vomiting—Trandolapril—coronary artery disease	4.79e-05	0.000449	CcSEcCtD
Lidocaine—Vomiting—Enalapril—coronary artery disease	4.77e-05	0.000447	CcSEcCtD
Lidocaine—Hypotension—Lisinopril—coronary artery disease	4.76e-05	0.000446	CcSEcCtD
Lidocaine—Dizziness—Captopril—coronary artery disease	4.75e-05	0.000446	CcSEcCtD
Lidocaine—Rash—Trandolapril—coronary artery disease	4.75e-05	0.000445	CcSEcCtD
Lidocaine—Dermatitis—Trandolapril—coronary artery disease	4.74e-05	0.000445	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Timolol—coronary artery disease	4.74e-05	0.000444	CcSEcCtD
Lidocaine—Rash—Enalapril—coronary artery disease	4.73e-05	0.000443	CcSEcCtD
Lidocaine—Dermatitis—Enalapril—coronary artery disease	4.72e-05	0.000443	CcSEcCtD
Lidocaine—Headache—Trandolapril—coronary artery disease	4.72e-05	0.000442	CcSEcCtD
Lidocaine—Vomiting—Telmisartan—coronary artery disease	4.7e-05	0.000441	CcSEcCtD
Lidocaine—Asthenia—Losartan—coronary artery disease	4.7e-05	0.000441	CcSEcCtD
Lidocaine—Headache—Enalapril—coronary artery disease	4.7e-05	0.00044	CcSEcCtD
Lidocaine—Pain—Timolol—coronary artery disease	4.69e-05	0.00044	CcSEcCtD
Lidocaine—Nausea—Niacin—coronary artery disease	4.68e-05	0.000438	CcSEcCtD
Lidocaine—Rash—Telmisartan—coronary artery disease	4.66e-05	0.000437	CcSEcCtD
Lidocaine—Dermatitis—Telmisartan—coronary artery disease	4.66e-05	0.000437	CcSEcCtD
Lidocaine—Headache—Telmisartan—coronary artery disease	4.63e-05	0.000434	CcSEcCtD
Lidocaine—Feeling abnormal—Ramipril—coronary artery disease	4.63e-05	0.000434	CcSEcCtD
Lidocaine—Dizziness—Perindopril—coronary artery disease	4.62e-05	0.000433	CcSEcCtD
Lidocaine—Nausea—Pravastatin—coronary artery disease	4.6e-05	0.000432	CcSEcCtD
Lidocaine—Paraesthesia—Lisinopril—coronary artery disease	4.57e-05	0.000429	CcSEcCtD
Lidocaine—Vomiting—Captopril—coronary artery disease	4.57e-05	0.000429	CcSEcCtD
Lidocaine—Dyspnoea—Lisinopril—coronary artery disease	4.54e-05	0.000426	CcSEcCtD
Lidocaine—Rash—Captopril—coronary artery disease	4.53e-05	0.000425	CcSEcCtD
Lidocaine—Dermatitis—Captopril—coronary artery disease	4.53e-05	0.000425	CcSEcCtD
Lidocaine—Somnolence—Lisinopril—coronary artery disease	4.53e-05	0.000424	CcSEcCtD
Lidocaine—Feeling abnormal—Timolol—coronary artery disease	4.52e-05	0.000424	CcSEcCtD
Lidocaine—Headache—Captopril—coronary artery disease	4.5e-05	0.000422	CcSEcCtD
Lidocaine—Dizziness—Furosemide—coronary artery disease	4.49e-05	0.000421	CcSEcCtD
Lidocaine—Nausea—Trandolapril—coronary artery disease	4.47e-05	0.000419	CcSEcCtD
Lidocaine—Urticaria—Ramipril—coronary artery disease	4.46e-05	0.000418	CcSEcCtD
Lidocaine—Nausea—Enalapril—coronary artery disease	4.45e-05	0.000418	CcSEcCtD
Lidocaine—Vomiting—Perindopril—coronary artery disease	4.44e-05	0.000416	CcSEcCtD
Lidocaine—Rash—Perindopril—coronary artery disease	4.4e-05	0.000413	CcSEcCtD
Lidocaine—Dermatitis—Perindopril—coronary artery disease	4.4e-05	0.000412	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.4e-05	0.000412	CcSEcCtD
Lidocaine—Nausea—Telmisartan—coronary artery disease	4.39e-05	0.000412	CcSEcCtD
Lidocaine—Headache—Perindopril—coronary artery disease	4.37e-05	0.00041	CcSEcCtD
Lidocaine—Urticaria—Timolol—coronary artery disease	4.36e-05	0.000409	CcSEcCtD
Lidocaine—Pain—Lisinopril—coronary artery disease	4.35e-05	0.000408	CcSEcCtD
Lidocaine—Dizziness—Losartan—coronary artery disease	4.33e-05	0.000406	CcSEcCtD
Lidocaine—Vomiting—Furosemide—coronary artery disease	4.31e-05	0.000405	CcSEcCtD
Lidocaine—Rash—Furosemide—coronary artery disease	4.28e-05	0.000401	CcSEcCtD
Lidocaine—Dermatitis—Furosemide—coronary artery disease	4.27e-05	0.000401	CcSEcCtD
Lidocaine—Nausea—Captopril—coronary artery disease	4.27e-05	0.0004	CcSEcCtD
Lidocaine—Headache—Furosemide—coronary artery disease	4.25e-05	0.000399	CcSEcCtD
Lidocaine—Feeling abnormal—Lisinopril—coronary artery disease	4.2e-05	0.000393	CcSEcCtD
Lidocaine—Vomiting—Losartan—coronary artery disease	4.16e-05	0.00039	CcSEcCtD
Lidocaine—Nausea—Perindopril—coronary artery disease	4.15e-05	0.000389	CcSEcCtD
Lidocaine—Hypersensitivity—Ramipril—coronary artery disease	4.14e-05	0.000388	CcSEcCtD
Lidocaine—Rash—Losartan—coronary artery disease	4.13e-05	0.000387	CcSEcCtD
Lidocaine—Dermatitis—Losartan—coronary artery disease	4.12e-05	0.000387	CcSEcCtD
Lidocaine—Headache—Losartan—coronary artery disease	4.1e-05	0.000385	CcSEcCtD
Lidocaine—Urticaria—Lisinopril—coronary artery disease	4.05e-05	0.000379	CcSEcCtD
Lidocaine—Hypersensitivity—Timolol—coronary artery disease	4.04e-05	0.000379	CcSEcCtD
Lidocaine—Nausea—Furosemide—coronary artery disease	4.03e-05	0.000378	CcSEcCtD
Lidocaine—Asthenia—Ramipril—coronary artery disease	4.03e-05	0.000378	CcSEcCtD
Lidocaine—Asthenia—Timolol—coronary artery disease	3.94e-05	0.000369	CcSEcCtD
Lidocaine—Nausea—Losartan—coronary artery disease	3.89e-05	0.000365	CcSEcCtD
Lidocaine—Hypersensitivity—Lisinopril—coronary artery disease	3.75e-05	0.000352	CcSEcCtD
Lidocaine—Dizziness—Ramipril—coronary artery disease	3.71e-05	0.000348	CcSEcCtD
Lidocaine—Asthenia—Lisinopril—coronary artery disease	3.65e-05	0.000343	CcSEcCtD
Lidocaine—Dizziness—Timolol—coronary artery disease	3.63e-05	0.00034	CcSEcCtD
Lidocaine—Vomiting—Ramipril—coronary artery disease	3.57e-05	0.000335	CcSEcCtD
Lidocaine—Rash—Ramipril—coronary artery disease	3.54e-05	0.000332	CcSEcCtD
Lidocaine—Dermatitis—Ramipril—coronary artery disease	3.54e-05	0.000332	CcSEcCtD
Lidocaine—Headache—Ramipril—coronary artery disease	3.52e-05	0.00033	CcSEcCtD
Lidocaine—Vomiting—Timolol—coronary artery disease	3.49e-05	0.000327	CcSEcCtD
Lidocaine—Rash—Timolol—coronary artery disease	3.46e-05	0.000325	CcSEcCtD
Lidocaine—Dermatitis—Timolol—coronary artery disease	3.46e-05	0.000324	CcSEcCtD
Lidocaine—Headache—Timolol—coronary artery disease	3.44e-05	0.000322	CcSEcCtD
Lidocaine—Dizziness—Lisinopril—coronary artery disease	3.37e-05	0.000316	CcSEcCtD
Lidocaine—Nausea—Ramipril—coronary artery disease	3.33e-05	0.000313	CcSEcCtD
Lidocaine—Nausea—Timolol—coronary artery disease	3.26e-05	0.000306	CcSEcCtD
Lidocaine—Vomiting—Lisinopril—coronary artery disease	3.24e-05	0.000304	CcSEcCtD
Lidocaine—Rash—Lisinopril—coronary artery disease	3.21e-05	0.000301	CcSEcCtD
Lidocaine—Dermatitis—Lisinopril—coronary artery disease	3.21e-05	0.000301	CcSEcCtD
Lidocaine—Headache—Lisinopril—coronary artery disease	3.19e-05	0.000299	CcSEcCtD
Lidocaine—Nausea—Lisinopril—coronary artery disease	3.02e-05	0.000284	CcSEcCtD
Lidocaine—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.74e-06	2.34e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KIT—coronary artery disease	1.73e-06	2.33e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SDC1—coronary artery disease	1.73e-06	2.32e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPP2CA—coronary artery disease	1.72e-06	2.31e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PLCB1—coronary artery disease	1.71e-06	2.31e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CAT—coronary artery disease	1.71e-06	2.3e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GGT1—coronary artery disease	1.71e-06	2.3e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GOT1—coronary artery disease	1.71e-06	2.3e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.7e-06	2.29e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.7e-06	2.29e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PPARG—coronary artery disease	1.7e-06	2.28e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—coronary artery disease	1.69e-06	2.27e-05	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—coronary artery disease	1.69e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOA5—coronary artery disease	1.69e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—POMC—coronary artery disease	1.67e-06	2.25e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.67e-06	2.24e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—coronary artery disease	1.67e-06	2.24e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GSK3B—coronary artery disease	1.66e-06	2.24e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOB—coronary artery disease	1.66e-06	2.24e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.66e-06	2.23e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—P4HB—coronary artery disease	1.65e-06	2.22e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—coronary artery disease	1.65e-06	2.22e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CREB1—coronary artery disease	1.65e-06	2.22e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—POMC—coronary artery disease	1.65e-06	2.22e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.65e-06	2.22e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.63e-06	2.19e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.63e-06	2.19e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.63e-06	2.19e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.62e-06	2.18e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.62e-06	2.18e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL2—coronary artery disease	1.62e-06	2.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6R—coronary artery disease	1.61e-06	2.17e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GGT1—coronary artery disease	1.61e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GOT1—coronary artery disease	1.61e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AGT—coronary artery disease	1.61e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GOT1—coronary artery disease	1.6e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GGT1—coronary artery disease	1.6e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CTGF—coronary artery disease	1.59e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—NOS3—coronary artery disease	1.59e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—LPL—coronary artery disease	1.59e-06	2.14e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1—coronary artery disease	1.59e-06	2.14e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK1—coronary artery disease	1.58e-06	2.13e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.58e-06	2.12e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GOT2—coronary artery disease	1.58e-06	2.12e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—APOE—coronary artery disease	1.57e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AGT—coronary artery disease	1.57e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—APOA1—coronary artery disease	1.56e-06	2.09e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GPX1—coronary artery disease	1.55e-06	2.08e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—APOE—coronary artery disease	1.54e-06	2.07e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTP1—coronary artery disease	1.53e-06	2.06e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—VCAN—coronary artery disease	1.53e-06	2.06e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—coronary artery disease	1.53e-06	2.05e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.52e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—APOA1—coronary artery disease	1.52e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.52e-06	2.04e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HMOX1—coronary artery disease	1.51e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CD36—coronary artery disease	1.51e-06	2.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SERPINE1—coronary artery disease	1.51e-06	2.03e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CAT—coronary artery disease	1.49e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.49e-06	2e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—DCN—coronary artery disease	1.47e-06	1.98e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NOS3—coronary artery disease	1.46e-06	1.96e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGF2—coronary artery disease	1.46e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—coronary artery disease	1.46e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.45e-06	1.95e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOB—coronary artery disease	1.45e-06	1.95e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.45e-06	1.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK1—coronary artery disease	1.44e-06	1.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOS3—coronary artery disease	1.44e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.43e-06	1.93e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.43e-06	1.93e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.43e-06	1.93e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.43e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.43e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.43e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.42e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.41e-06	1.9e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—coronary artery disease	1.41e-06	1.9e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.41e-06	1.89e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CAT—coronary artery disease	1.41e-06	1.89e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JAK2—coronary artery disease	1.4e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LIPC—coronary artery disease	1.4e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HBA1—coronary artery disease	1.4e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.4e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.4e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CAT—coronary artery disease	1.39e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOC3—coronary artery disease	1.39e-06	1.87e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—LPL—coronary artery disease	1.38e-06	1.86e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LDLR—coronary artery disease	1.38e-06	1.86e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—coronary artery disease	1.37e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PPARG—coronary artery disease	1.37e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOB—coronary artery disease	1.37e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.36e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.36e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GGT1—coronary artery disease	1.36e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GOT1—coronary artery disease	1.36e-06	1.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—coronary artery disease	1.36e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AGT—coronary artery disease	1.36e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOB—coronary artery disease	1.35e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—POMC—coronary artery disease	1.35e-06	1.82e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GPX1—coronary artery disease	1.35e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—coronary artery disease	1.35e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GCLC—coronary artery disease	1.35e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CETP—coronary artery disease	1.35e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPARG—coronary artery disease	1.34e-06	1.8e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—coronary artery disease	1.34e-06	1.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK1—coronary artery disease	1.33e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SDC1—coronary artery disease	1.33e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOE—coronary artery disease	1.33e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.33e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POMC—coronary artery disease	1.32e-06	1.78e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.32e-06	1.77e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOA1—coronary artery disease	1.32e-06	1.77e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CD36—coronary artery disease	1.32e-06	1.77e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—LPL—coronary artery disease	1.3e-06	1.75e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.3e-06	1.75e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—LPL—coronary artery disease	1.29e-06	1.74e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL8—coronary artery disease	1.28e-06	1.72e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GPX1—coronary artery disease	1.27e-06	1.71e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GPX1—coronary artery disease	1.26e-06	1.7e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.26e-06	1.69e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.26e-06	1.69e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.26e-06	1.69e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—coronary artery disease	1.25e-06	1.68e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—coronary artery disease	1.25e-06	1.68e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CD36—coronary artery disease	1.24e-06	1.67e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—coronary artery disease	1.23e-06	1.66e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.23e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CD36—coronary artery disease	1.23e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.23e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.22e-06	1.65e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—coronary artery disease	1.22e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.22e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.22e-06	1.64e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—coronary artery disease	1.21e-06	1.63e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.21e-06	1.63e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.21e-06	1.63e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.21e-06	1.62e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—coronary artery disease	1.2e-06	1.62e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CAT—coronary artery disease	1.19e-06	1.6e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—coronary artery disease	1.19e-06	1.6e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AGT—coronary artery disease	1.18e-06	1.59e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NOS3—coronary artery disease	1.18e-06	1.58e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.17e-06	1.58e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.16e-06	1.57e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOE—coronary artery disease	1.16e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARG—coronary artery disease	1.16e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOB—coronary artery disease	1.16e-06	1.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—coronary artery disease	1.16e-06	1.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—coronary artery disease	1.16e-06	1.55e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NOS3—coronary artery disease	1.15e-06	1.55e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOA1—coronary artery disease	1.15e-06	1.54e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POMC—coronary artery disease	1.14e-06	1.54e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.13e-06	1.51e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.12e-06	1.51e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—coronary artery disease	1.12e-06	1.51e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AGT—coronary artery disease	1.12e-06	1.5e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—coronary artery disease	1.11e-06	1.49e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AGT—coronary artery disease	1.11e-06	1.49e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—LPL—coronary artery disease	1.11e-06	1.49e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—coronary artery disease	1.1e-06	1.48e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOE—coronary artery disease	1.09e-06	1.47e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.09e-06	1.46e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOE—coronary artery disease	1.08e-06	1.46e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.08e-06	1.45e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GPX1—coronary artery disease	1.08e-06	1.45e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.08e-06	1.45e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOA1—coronary artery disease	1.07e-06	1.44e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.05e-06	1.42e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.05e-06	1.42e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.05e-06	1.42e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CD36—coronary artery disease	1.05e-06	1.41e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—coronary artery disease	1.04e-06	1.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—coronary artery disease	1.04e-06	1.39e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.04e-06	1.39e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.03e-06	1.38e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—coronary artery disease	1.02e-06	1.38e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—coronary artery disease	1.02e-06	1.38e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARG—coronary artery disease	1.01e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NOS3—coronary artery disease	9.98e-07	1.34e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POMC—coronary artery disease	9.97e-07	1.34e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—coronary artery disease	9.95e-07	1.34e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARG—coronary artery disease	9.52e-07	1.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—coronary artery disease	9.52e-07	1.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.45e-07	1.27e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AGT—coronary artery disease	9.45e-07	1.27e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—coronary artery disease	9.45e-07	1.27e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARG—coronary artery disease	9.44e-07	1.27e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POMC—coronary artery disease	9.39e-07	1.26e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.37e-07	1.26e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK1—coronary artery disease	9.34e-07	1.26e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.32e-07	1.25e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POMC—coronary artery disease	9.31e-07	1.25e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOE—coronary artery disease	9.26e-07	1.25e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CAT—coronary artery disease	9.2e-07	1.24e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOA1—coronary artery disease	9.16e-07	1.23e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—coronary artery disease	9.13e-07	1.23e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—coronary artery disease	9.09e-07	1.22e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—coronary artery disease	8.97e-07	1.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOB—coronary artery disease	8.93e-07	1.2e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.77e-07	1.18e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NOS3—coronary artery disease	8.69e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—coronary artery disease	8.69e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—coronary artery disease	8.56e-07	1.15e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LPL—coronary artery disease	8.53e-07	1.15e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—coronary artery disease	8.49e-07	1.14e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPX1—coronary artery disease	8.32e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—coronary artery disease	8.22e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NOS3—coronary artery disease	8.19e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NOS3—coronary artery disease	8.12e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CD36—coronary artery disease	8.1e-07	1.09e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—coronary artery disease	8.1e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARG—coronary artery disease	8.07e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POMC—coronary artery disease	7.96e-07	1.07e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—coronary artery disease	7.95e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.68e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—coronary artery disease	7.49e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—coronary artery disease	7.43e-07	9.98e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—coronary artery disease	7.33e-07	9.85e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AGT—coronary artery disease	7.3e-07	9.81e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—coronary artery disease	7.25e-07	9.75e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—coronary artery disease	7.18e-07	9.65e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOE—coronary artery disease	7.15e-07	9.61e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOA1—coronary artery disease	7.07e-07	9.5e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NOS3—coronary artery disease	6.94e-07	9.33e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—coronary artery disease	6.71e-07	9.03e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	6.63e-07	8.92e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—coronary artery disease	6.62e-07	8.9e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—coronary artery disease	6.48e-07	8.71e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—coronary artery disease	6.35e-07	8.53e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARG—coronary artery disease	6.23e-07	8.37e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POMC—coronary artery disease	6.14e-07	8.26e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	5.61e-07	7.55e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—coronary artery disease	5.6e-07	7.53e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—coronary artery disease	5.42e-07	7.28e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NOS3—coronary artery disease	5.36e-07	7.2e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—coronary artery disease	5.3e-07	7.12e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.9e-07	6.58e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—coronary artery disease	4.89e-07	6.58e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	4.61e-07	6.2e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—coronary artery disease	4.59e-07	6.17e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	4.57e-07	6.14e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—coronary artery disease	4e-07	5.37e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.9e-07	5.25e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—coronary artery disease	3.77e-07	5.06e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—coronary artery disease	3.73e-07	5.02e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—coronary artery disease	3.19e-07	4.29e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.01e-07	4.05e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.46e-07	3.31e-06	CbGpPWpGaD
